Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.36 |
| ▸ | TSHR | P16473 | 1/20 | 0.36 |
| ▸ | HTT | P42858 | 1/20 | 0.35 |
| ▸ | FKBP5 | Q13451 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | DAGLA | Q9Y4D2 | 1/20 | 0.31 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8939183 | 0.83 | ALDH1A1 (0.49) | ALDH1A1TSHRHTTKDM4ENPSR1 | |
| Imidazole SCHEMBL4551598 | 0.74 | ALDH1A1 (0.41) | ALDH1A1FKBP5 | |
| Imidazole SCHEMBL28750264 | 0.72 | MAPT (0.50) | ALDH1A1FKBP5KDM4EKMT2A | |
| Imidazole SCHEMBL2541492 | 0.71 | ALDH1A1 (0.48) | ALDH1A1FKBP5 | |
| Imidazole SCHEMBL29140670 | 0.71 | MAPT (0.49) | ALDH1A1FKBP5KDM4EKMT2A | |
| Benzylic Acid SCHEMBL10563379 | 0.70 | CYP2C9 (0.49) | ALDH1A1HTTFKBP5NPSR1KMT2A | |
| Imidazole SCHEMBL28904975 | 0.69 | ALDH1A1 (0.54) | ALDH1A1TSHRFKBP5KMT2A | |
| Allylbenzene SCHEMBL27805393 | 0.68 | ALDH1A1 (0.45) | ALDH1A1TSHRFKBP5 | |
| Acrylic Acid SCHEMBL2459820 | 0.67 | ALDH1A1 (0.56) | ALDH1A1FKBP5 | |
| Acrylic Acid SCHEMBL9807323 | 0.67 | ALDH1A1 (0.56) | ALDH1A1FKBP5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1318996-A2 | SUBSTITUTED IMIDAZOLES AS DUAL HISTAMINE H1 AND H3 AGONISTS OR ANTAGONISTS | Schering Corporation (US) | 2003-06-18 | — | — | EP | disclosed |
| EP-1318994-A2 | SUBSTITUTED IMIDAZOLES AS DUAL HISTAMINE H1 AND H3 AGONISTS OR ANTAGONISTS | Schering Corporation (US) | 2003-06-18 | — | — | EP | disclosed |
| WO-2002044141-A2 | SUBSTITUTED IMIDAZOLES AS DUAL HISTAMINE H1 AND H3 AGONISTS OR ANTAGONISTS | SCHERING CORPORATION (US) | 2002-06-06 | — | — | WO | disclosed |
| WO-2002024659-A2 | SUBSTITUTED IMIDAZOLES AS DUAL HISTAMINE H1 AND H3 AGONISTS OR ANTGONISTS | SCHERING CORPORATION (US) | 2002-03-28 | — | — | WO | disclosed |